JP3830711B2 - Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative - Google Patents

Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative Download PDF

Info

Publication number
JP3830711B2
JP3830711B2 JP2000019165A JP2000019165A JP3830711B2 JP 3830711 B2 JP3830711 B2 JP 3830711B2 JP 2000019165 A JP2000019165 A JP 2000019165A JP 2000019165 A JP2000019165 A JP 2000019165A JP 3830711 B2 JP3830711 B2 JP 3830711B2
Authority
JP
Japan
Prior art keywords
trifluoro
optical purity
hydroxy
aryl
optically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000019165A
Other languages
Japanese (ja)
Other versions
JP2001213838A (en
Inventor
章央 石井
正富 金井
崇 速水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Glass Co Ltd
Original Assignee
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Glass Co Ltd filed Critical Central Glass Co Ltd
Priority to JP2000019165A priority Critical patent/JP3830711B2/en
Priority to US09/770,671 priority patent/US6642409B2/en
Publication of JP2001213838A publication Critical patent/JP2001213838A/en
Priority to US10/202,833 priority patent/US6833468B2/en
Priority to US10/212,840 priority patent/US6639100B2/en
Application granted granted Critical
Publication of JP3830711B2 publication Critical patent/JP3830711B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、光学純度の低い、一般式[1]
【0002】
【化2】

Figure 0003830711
【0003】
[式中、Xは、水素、C1-6アルキル、C1-6アルコキシまたはハロゲン原子(F、Cl、BrまたはI)を示し、*は不斉炭素を表す]で示される4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の光学純度を向上させる精製法に関する。本発明で対象とする化合物は、医薬、農薬および強誘電性液晶を初めとする機能性材料の重要中間体である光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体の前駆体である。
【0004】
【従来の技術】
光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体は、医薬、農薬および強誘電性液晶を初めとする機能性材料の重要中間体である。光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体の光学純度を向上させる精製法については、いくつかの方法が知られている。例えば、Helvetica Chimica Acta,67,1843,1984には、光学純度の低い4,4,4−トリフルオロ−3−ヒドロキシブタン酸エチルの光学純度を向上させる精製法として、再結晶操作におけるラセミ結晶の優先的析出により、母液の光学純度を向上させる精製法の記載がある。
【0005】
しかしながら、析出したラセミ結晶の融点が16℃で、室温ではオイル状になるため、工業的観点からみた場合、再結晶、濾過等の一連の操作を低温下で行う必要があり、設備的に負荷がかかる。また、光学純度の低い4,4,4−トリフルオロ−3−ヒドロキシブタン酸エチルの3,5−ジニトロベンゾエート体の再結晶操作により、光学純度を向上させる精製法の記載もあるが、アルコールからエステルへの誘導および精製後の加水分解工程を必要とし、操作が煩雑である。
【0006】
一方、欧州特許公開EP−A−0424244号明細書には、光学活性α−フェニルエチルアミンと4,4,4−トリフルオロ−3−ヒドロキシブタン酸のジアステレオマー塩の再結晶操作による光学分割の方法が記載されている。しかしながら、この方法は、高価な分割剤を必要とし、更に光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸を再生させるために、中和抽出等の操作を必要とする。
【0007】
このように、光学純度の高い4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体を得るための、工業的に簡便で且つ効率の良い精製法はなかった。
【0008】
【発明が解決しようとする課題】
本発明の目的は、工業的に簡便で且つ効率の良い、光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体の前駆体である光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の光学純度を向上させる精製法を提供する。
【0009】
【課題を解決するための手段】
上記の課題を解決すべく、鋭意検討した結果、光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体の前駆体である光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体から、ラセミ結晶を優先的に析出させ、残存物の光学純度を向上させる精製法を見いだした。
すなわち、本発明は、
(1)光学純度の低い一般式[1]
【0010】
【化3】
Figure 0003830711
【0011】
[式中、Xは、水素、C1-6アルキル、C1-6アルコキシまたはハロゲン原子(F、Cl、BrまたはI)を示し、*は不斉炭素を表す]で示される4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体から、ラセミ結晶を優先的に析出させ、残存物の光学純度を向上させることを特徴とする、光学純度の高い一般式[1]で示される光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の精製法である。
【0012】
かかる精製法においては、必要により再結晶溶媒を使用したり、ラセミ種結晶を添加する。また、これらの方法を繰り返し行うことにより、更に光学純度の高い4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体を得ることができる。
【0013】
ここで得られた光学純度の高い4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体は、ケトン類の多置換側に酸素原子を導入するベイヤー・ビリガー酸化により、光学純度を損なうことなく、光学純度の高い4,4,4−トリフルオロ−3−ヒドロキシブタン酸アリールエステル誘導体に変換することができる。
【0014】
【化4】
Figure 0003830711
【0015】
【発明の実施の形態】
本発明に用いられる光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体において、Xは、水素または置換基を示し、置換基の位置は、オルト位またはパラ位のものが好ましく、特に、パラ位のものが好ましい。
【0016】
置換基としては、炭素数1〜6の直鎖または分岐状の低級アルキル基または低級アルコキシ基およびハロゲン原子が挙げられる。低級アルキル基としては、例えば、メチル、エチル、n−プロピル、i−プロピル、n−ブチル、i−ブチル、sec−ブチル、tert−ブチル、n−ペンチル、n−ヘキシル等が挙げられる。低級アルコキシ基としては、例えば、メトキシ、エトキシ、n−プロポキシ、i−プロポキシ、n−ブトキシ、i−ブトキシ、sec−ブトキシ、tert−ブトキシ、n−ペンチロキシ、n−ヘキシロキシ等が挙げられる。ハロゲン原子としては、フッ素、塩素、臭素、ヨウ素が挙げられる。
【0017】
一般式[1]で示される光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体は、どのような方法で製造されたものでもよく、例えば、光学活性ビナフトール−チタン錯体の存在下、α−メトキシスチレン誘導体とフルオラールを反応させることにより得られるフリーデル−クラフツ型生成物を酸加水分解することで得られる。
【0018】
本発明の光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の精製法は、ラセミ結晶を優先的に析出させ、残存物の光学純度を向上させることを特徴とする方法であり、この手法は、特に、本発明で対象とする化合物において有効である。なぜならば、4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体は、同一分子内に水素結合に関与できるヒドロキシル基とケトン基を併せ持ち、S体とR体の互いのヒドロキシル基とカルボニル基の間で水素結合をつくり、アリール基が積層構造をとることがラセミ単結晶のX線結晶構造解析により明らかにされており、優先的にラセミ結晶が析出しやすい化合物群である。
【0019】
本発明における精製法では、ラセミ結晶を析出させる場合、再結晶溶媒を使用する場合と使用しない場合があるが、これは、用いる原料の光学純度、目標とする精製後の光学純度および回収率等により適宜使い分ければよい。また、ラセミ種結晶を添加することにより、円滑に且つ効率良くラセミ結晶を析出させることができる。
【0020】
本発明の対象とする光学純度の低い4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体は、R体またはS体のいずれを過剰に含んでいてもよい。その光学純度に関しては、5%ee以上のものが好ましい。
【0021】
本発明における再結晶溶媒は、光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体と反応しないものであれば、特に、制限はなく、用いる原料の光学純度、目標とする精製後の光学純度および回収率等により適宜決めればよい。かかる再結晶溶媒としては、脂肪族炭化水素系(例えば、n−ペンタン、n−ヘキサン、c−ヘキサン、n−ヘプタン等)、芳香族炭化水素系(例えば、ベンゼン、トルエン、エチルベンゼン、キシレン等)、ハロゲン化炭化水素系(例えば、塩化メチレン、クロロホルム、1,2−ジクロロエタン等)、エーテル系(例えば、ジエチルエーテル、メチル−tert−ブチルエーテル、テトラヒドロフラン、1,4−ジオキサン等)、エステル系(例えば、酢酸エチル、酢酸n−ブチル等)、ケトン系(例えば、アセトン、メチルエチルケトン等)等が挙げられる。その中でも、n−へキサン、トルエン、酢酸エチルおよびアセトンが好ましく、特にn−ヘキサンがより好ましい。これらの溶媒は、単独または組み合わせて用いることができる。
【0022】
再結晶操作の温度条件は、使用する溶媒の沸点および凝固点により適宜決めることができ、一般には、室温(25℃)から溶媒の沸点付近の温度で、用いる原料を溶解させ、−40〜80℃でラセミ結晶を析出させることができる。溶媒として、n−ヘキサン(凝固点−94℃、沸点69℃)を使用する場合には、30〜69℃で原料を溶解させ、−20〜65℃でラセミ結晶を析出させるのが好ましい。
【0023】
用いる再結晶溶媒の量は、用いる原料が完全に溶解する範囲であれば特に制限はなく、用いる原料の光学純度、目標とする精製後の光学純度および回収率等により適宜決めればよい。
【0024】
用いるラセミ種結晶の量は、用いる原料に対して、1/10〜1/10000重量の添加が好ましく、特に1/20〜1/1000重量の添加がより好ましい。
【0025】
本発明においては、残存物の光学純度が向上するため、析出したラセミ結晶を濾過等で取り除くことにより、光学純度の高い4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体を回収する。
【0026】
これら光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の光学純度は、キラルHPLC分析(ダイセルOD−H、n−ヘキサン:i−プロパノール=95:5、254nm)にてR体およびS体の各ピーク面積を測定し、エナンチオマー過剰率(ee%)で示した。
【0027】
【実施例】
以下、実施例により本発明の実施の形態を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。
[実施例1]
再結晶溶媒を使用し、ラセミ種結晶を添加しない系−1
4,4,4−トリフルオロ−3−ヒドロキシ−1−フェニル−1−ブタノン 15.9mg(43%ee、R)をn−ヘキサン0.8ml(50ml/g)に加熱溶解し、室温で3時間、5℃で12時間放置後、上澄液の光学純度を測定したところ、85%ee(R)であった。析出した結晶を濾過し、n−ヘキサンで洗浄し、真空乾燥後、光学純度を測定したところ、4%ee(R)であった。光学純度の測定は、キラルHPLC分析(ダイセルOD−H、n−ヘキサン:i−プロパノール=95:5、254nm)で行った。
[実施例2]
再結晶溶媒を使用し、ラセミ種結晶を添加しない系−2
4,4,4−トリフルオロ−3−ヒドロキシ−1−フェニル−1−ブタノン 165.3mg(88%ee、R)をn−ヘキサン5ml(30ml/g)に加熱溶解し、室温で3時間、5℃で12時間放置後、上澄液の光学純度を測定したところ、94%ee(R)であった。なお、光学純度の測定は、実施例1に記載した方法で行った。
[実施例3]
再結晶溶媒を使用せず、ラセミ種結晶を添加しない系
4,4,4−トリフルオロ−3−ヒドロキシ−1−フェニル−1−ブタノン 2g(60%ee、R)を酢酸エチル3mlに加熱溶解し、開放系で酢酸エチルを自然に蒸発させながら、室温で3日間放置後、結晶を含まないオイル状の残存物の光学純度を測定したところ、85%ee(R)であった。析出した結晶を濾過し、n−ヘキサンで洗浄し、真空乾燥後、光学純度を測定したところ、1%ee(R)であった。なお、光学純度の測定は、実施例1に記載した方法で行った。
[実施例4]
再結晶溶媒を使用し、ラセミ種結晶を添加する系−1
4,4,4−トリフルオロ−3−ヒドロキシ−1−フェニル−1−ブタノン
1.82g(31%ee,R)をn−ヘキサン36.4ml(20ml/g)に加熱溶解し、熱時、ラセミ種結晶18.2mg(1/100重量)を添加し、室温で2.5時間放置後、析出した結晶を濾過し、n−ヘキサン9.1ml(5ml/g)で洗浄し、真空乾燥後、結晶1.33gと母液濃縮物0.53gを回収した。それぞれの光学純度を測定したところ、6%ee(R)と95%ee(R、R体の理論回収率は91%)であった。なお、光学純度の測定は、実施例1に記載した方法で行った。
[実施例5]
再結晶溶媒を使用し、ラセミ種結晶を添加する系−2
4,4,4−トリフルオロ−3−ヒドロキシ−1−フェニル−1−ブタノン
1.32g(6%ee,R)をn−ヘキサン39.5ml(30ml/g)に加熱溶解し、熱時、ラセミ種結晶13.2mg(1/100重量)を添加し、室温で3日間放置後、上澄液の光学純度を測定したところ、63%ee(R)であった。析出した結晶を濾過し、n−ヘキサン9.9ml(7.5ml/g)で洗浄し、真空乾燥後、結晶1.18gと母液濃縮物0.14gを回収した。それぞれの光学純度を測定したところ、0.2%ee(R)と57%ee(R、R体の理論回収率は>95%)であった。なお、光学純度の測定は、実施例1に記載した方法で行った。
[実施例6]
再結晶溶媒を使用し、ラセミ種結晶を添加する系−3
4,4,4−トリフルオロ−3−ヒドロキシ−1−フェニル−1−ブタノン
0.14g(57%ee,R)をn−ヘキサン4.1ml(30ml/g)に加熱溶解し、熱時、ラセミ種結晶1.4mg(1/100重量)を添加し、以下の▲1▼〜▲3▼の順番で各放置温度に対する上澄液の光学純度を測定した。
【0028】
Figure 0003830711
なお、光学純度の測定は、実施例1に記載した方法で行った。
【0029】
【発明の効果】
医薬、農薬および強誘電性液晶を初めとする機能性材料の重要中間体である光学活性4,4,4−トリフルオロ−3−ヒドロキシブタン酸誘導体の前駆体である光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の光学純度を工業的に簡便で且つ効率良く向上させることができる。[0001]
BACKGROUND OF THE INVENTION
The present invention provides a general formula [1] having a low optical purity.
[0002]
[Chemical 2]
Figure 0003830711
[0003]
[Wherein X represents hydrogen, C 1-6 alkyl, C 1-6 alkoxy or a halogen atom (F, Cl, Br or I), * represents an asymmetric carbon] The present invention relates to a purification method for improving the optical purity of a 4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative. The compounds targeted by the present invention are precursors of optically active 4,4,4-trifluoro-3-hydroxybutanoic acid derivatives which are important intermediates for functional materials such as pharmaceuticals, agricultural chemicals and ferroelectric liquid crystals. It is.
[0004]
[Prior art]
Optically active 4,4,4-trifluoro-3-hydroxybutanoic acid derivatives are important intermediates for functional materials including pharmaceuticals, agricultural chemicals and ferroelectric liquid crystals. As a purification method for improving the optical purity of the optically active 4,4,4-trifluoro-3-hydroxybutanoic acid derivative, several methods are known. For example, Helvetica Chimica Acta, 67,1843,1984 describes a racemic crystal in a recrystallization operation as a purification method for improving the optical purity of ethyl 4,4,4-trifluoro-3-hydroxybutanoate having a low optical purity. There is a description of a purification method that improves the optical purity of the mother liquor by preferential precipitation.
[0005]
However, since the melting point of the precipitated racemic crystal is 16 ° C. and becomes oily at room temperature, it is necessary to perform a series of operations such as recrystallization and filtration at a low temperature from an industrial point of view. It takes. In addition, there is a description of a purification method for improving optical purity by recrystallization of 3,4-dinitrobenzoate of 4,4,4-trifluoro-3-hydroxybutanoate having low optical purity. It requires a hydrolysis step after induction and purification to an ester, and the operation is complicated.
[0006]
On the other hand, EP-A-0424244 discloses an optical resolution by recrystallization operation of a diastereomeric salt of optically active α-phenylethylamine and 4,4,4-trifluoro-3-hydroxybutanoic acid. A method is described. However, this method requires an expensive resolving agent and further requires an operation such as neutralization extraction to regenerate the optically active 4,4,4-trifluoro-3-hydroxybutanoic acid.
[0007]
Thus, there was no industrially simple and efficient purification method for obtaining a 4,4,4-trifluoro-3-hydroxybutanoic acid derivative with high optical purity.
[0008]
[Problems to be solved by the invention]
An object of the present invention is to provide an optically active 4,4,4-trifluoro-3 which is a precursor of an optically active 4,4,4-trifluoro-3-hydroxybutanoic acid derivative that is industrially simple and efficient. Provided is a purification method for improving the optical purity of a hydroxy-1-aryl-1-butanone derivative.
[0009]
[Means for Solving the Problems]
As a result of intensive studies to solve the above-mentioned problems, optically active 4,4,4-trifluoro-3-hydroxy-hydroxy-a precursor of an optically active 4,4,4-trifluoro-3-hydroxybutanoic acid derivative is obtained. From the 1-aryl-1-butanone derivative, a purification method was found in which racemic crystals were preferentially precipitated and the optical purity of the residue was improved.
That is, the present invention
(1) General formula [1] with low optical purity
[0010]
[Chemical 3]
Figure 0003830711
[0011]
[Wherein X represents hydrogen, C 1-6 alkyl, C 1-6 alkoxy or a halogen atom (F, Cl, Br or I), * represents an asymmetric carbon] A racemic crystal is preferentially precipitated from a 4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative to improve the optical purity of the residue, and the general formula [1 ] The purification method of the optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative shown by this.
[0012]
In such a purification method, if necessary, a recrystallization solvent is used, or a racemic seed crystal is added. Further, by repeating these methods, a 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative having higher optical purity can be obtained.
[0013]
The 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative having high optical purity obtained here was subjected to Bayer-Billiger oxidation in which an oxygen atom was introduced into the polysubstituted side of the ketones. Without impairing the optical purity, it can be converted to a 4,4,4-trifluoro-3-hydroxybutanoic acid aryl ester derivative having a high optical purity.
[0014]
[Formula 4]
Figure 0003830711
[0015]
DETAILED DESCRIPTION OF THE INVENTION
In the optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative used in the present invention, X represents hydrogen or a substituent, and the position of the substituent is ortho or para. The one at the position is preferable, and the one at the para position is particularly preferable.
[0016]
Examples of the substituent include a linear or branched lower alkyl group or lower alkoxy group having 1 to 6 carbon atoms and a halogen atom. Examples of the lower alkyl group include methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, tert-butyl, n-pentyl, n-hexyl and the like. Examples of the lower alkoxy group include methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, sec-butoxy, tert-butoxy, n-pentyloxy, n-hexyloxy and the like. Examples of the halogen atom include fluorine, chlorine, bromine and iodine.
[0017]
The optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative represented by the general formula [1] may be produced by any method, for example, optically active binaphthol. -It can be obtained by acid hydrolysis of a Friedel-Crafts type product obtained by reacting an α-methoxystyrene derivative with fluoral in the presence of a titanium complex.
[0018]
The purification method of the optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative of the present invention is to preferentially precipitate racemic crystals and improve the optical purity of the residue. This method is particularly effective for the compounds targeted by the present invention. This is because the 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative has both a hydroxyl group and a ketone group that can participate in hydrogen bonding in the same molecule, and the S-form and R-form each other. A group of compounds in which racemic single crystals are preferentially precipitated, as a result of X-ray crystallographic analysis of racemic single crystals that a hydrogen bond is formed between the hydroxyl group and carbonyl group of the aryl group and the aryl group has a laminated structure. It is.
[0019]
In the purification method of the present invention, when a racemic crystal is precipitated, the recrystallization solvent may or may not be used. This includes the optical purity of the raw material used, the optical purity and recovery rate after the target purification, etc. May be used as appropriate. Further, by adding a racemic seed crystal, the racemic crystal can be precipitated smoothly and efficiently.
[0020]
The 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative having a low optical purity, which is the subject of the present invention, may contain an excess of either R-form or S-form. As for its optical purity, it is preferably 5% ee or more.
[0021]
The recrystallization solvent in the present invention is not particularly limited as long as it does not react with the optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative, and the optical purity of the raw material used is not limited. The target optical purity and the recovery rate may be appropriately determined. Examples of the recrystallization solvent include aliphatic hydrocarbons (eg, n-pentane, n-hexane, c-hexane, n-heptane, etc.), aromatic hydrocarbons (eg, benzene, toluene, ethylbenzene, xylene, etc.). Halogenated hydrocarbons (eg, methylene chloride, chloroform, 1,2-dichloroethane, etc.), ethers (eg, diethyl ether, methyl tert-butyl ether, tetrahydrofuran, 1,4-dioxane, etc.), ester (eg, , Ethyl acetate, n-butyl acetate, etc.), ketones (for example, acetone, methyl ethyl ketone, etc.) and the like. Among these, n-hexane, toluene, ethyl acetate and acetone are preferable, and n-hexane is particularly preferable. These solvents can be used alone or in combination.
[0022]
The temperature conditions for the recrystallization operation can be determined appropriately depending on the boiling point and freezing point of the solvent used. In general, the raw material used is dissolved at a temperature from room temperature (25 ° C.) to around the boiling point of the solvent, and −40 to 80 ° C. The racemic crystals can be precipitated with When n-hexane (freezing point −94 ° C., boiling point 69 ° C.) is used as the solvent, it is preferable to dissolve the raw material at 30 to 69 ° C. and to precipitate racemic crystals at −20 to 65 ° C.
[0023]
The amount of the recrystallization solvent to be used is not particularly limited as long as the raw material to be used is completely dissolved.
[0024]
The amount of the racemic seed crystal to be used is preferably 1/10 to 1/10000 weight addition, more preferably 1/20 to 1/1000 weight addition to the raw material used.
[0025]
In the present invention, since the optical purity of the residue is improved, 4,4,4-trifluoro-3-hydroxy-1-aryl-1- having high optical purity is obtained by removing the precipitated racemic crystal by filtration or the like. The butanone derivative is recovered.
[0026]
The optical purity of these optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivatives was determined by chiral HPLC analysis (Daicel OD-H, n-hexane: i-propanol = 95: 5, The peak areas of the R and S isomers were measured at 254 nm) and indicated by the enantiomeric excess (ee%).
[0027]
【Example】
Hereinafter, the embodiments of the present invention will be specifically described by way of examples. However, the present invention is not limited to these examples.
[Example 1]
System-1 that uses a recrystallization solvent and does not add racemic seed crystals
1,5.9 mg (43% ee, R) of 4,4,4-trifluoro-3-hydroxy-1-phenyl-1-butanone was dissolved in 0.8 ml of n-hexane (50 ml / g) by heating and dissolved at room temperature. After standing for 12 hours at 5 ° C., the optical purity of the supernatant was measured and found to be 85% ee (R). The precipitated crystals were filtered, washed with n-hexane, vacuum dried, and the optical purity was measured and found to be 4% ee (R). The optical purity was measured by chiral HPLC analysis (Daicel OD-H, n-hexane: i-propanol = 95: 5, 254 nm).
[Example 2]
System-2 using a recrystallization solvent and not adding racemic seed crystals
165.3 mg (88% ee, R) of 4,4,4-trifluoro-3-hydroxy-1-phenyl-1-butanone was dissolved in 5 ml of n-hexane (30 ml / g) with heating, and at room temperature for 3 hours, After standing at 5 ° C. for 12 hours, the optical purity of the supernatant was measured and found to be 94% ee (R). The optical purity was measured by the method described in Example 1.
[Example 3]
The system 4,4,4-trifluoro-3-hydroxy-1-phenyl-1-butanone 2 g (60% ee, R), which does not use a recrystallization solvent and does not add racemic seed crystals, is dissolved in 3 ml of ethyl acetate by heating. Then, after standing for 3 days at room temperature while naturally evaporating ethyl acetate in an open system, the optical purity of the oily residue containing no crystals was measured and found to be 85% ee (R). The precipitated crystals were filtered, washed with n-hexane, dried in vacuo, and the optical purity was measured and found to be 1% ee (R). The optical purity was measured by the method described in Example 1.
[Example 4]
System-1 in which racemic seed crystal is added using recrystallization solvent
1.82, g (31% ee, R) of 4,4,4-trifluoro-3-hydroxy-1-phenyl-1-butanone was dissolved by heating in 36.4 ml (20 ml / g) of n-hexane, After adding racemic seed crystals (18.2 mg, 1/100 weight) and allowing to stand at room temperature for 2.5 hours, the precipitated crystals were filtered, washed with 9.1 ml (5 ml / g) of n-hexane, and vacuum dried. 1.33 g of crystals and 0.53 g of mother liquor concentrate were recovered. When the optical purity of each was measured, they were 6% ee (R) and 95% ee (theoretical recovery rate of R and R isomers was 91%). The optical purity was measured by the method described in Example 1.
[Example 5]
System-2 using a recrystallization solvent and adding racemic seed crystals
1.32 g (6% ee, R) of 4,4,4-trifluoro-3-hydroxy-1-phenyl-1-butanone was heated and dissolved in 39.5 ml (30 ml / g) of n-hexane, After adding 13.2 mg (1/100 weight) of racemic seed crystals and allowing to stand at room temperature for 3 days, the optical purity of the supernatant was measured and found to be 63% ee (R). The precipitated crystals were filtered, washed with 9.9 ml (7.5 ml / g) of n-hexane, and vacuum dried to recover 1.18 g of crystals and 0.14 g of mother liquor concentrate. Each optical purity was measured and found to be 0.2% ee (R) and 57% ee (theoretical recovery of R and R isomers was> 95%). The optical purity was measured by the method described in Example 1.
[Example 6]
System-3 using a recrystallization solvent and adding racemic seed crystals
0.14 g (57% ee, R) of 4,4,4-trifluoro-3-hydroxy-1-phenyl-1-butanone was dissolved by heating in 4.1 ml (30 ml / g) of n-hexane, Racemic seed crystals (1.4 mg, 1/100 weight) were added, and the optical purity of the supernatant was measured for each standing temperature in the order of (1) to (3) below.
[0028]
Figure 0003830711
The optical purity was measured by the method described in Example 1.
[0029]
【The invention's effect】
Optically active 4,4,4 which is a precursor of optically active 4,4,4-trifluoro-3-hydroxybutanoic acid derivatives which are important intermediates of functional materials such as pharmaceuticals, agricultural chemicals and ferroelectric liquid crystals The optical purity of the -trifluoro-3-hydroxy-1-aryl-1-butanone derivative can be improved industrially simply and efficiently.

Claims (4)

一般式[1]
Figure 0003830711
[式中、Xは、水素、C1-6アルキル、C1-6アルコキシまたはハロゲン原子(F、Cl、BrまたはI)を示し、*は不斉炭素を表す]で示される光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体から、ラセミ結晶を優先的に析出させ、残存物の光学純度を向上させることを特徴とする、光学純度の高い一般式[1]で示される光学活性4,4,4−トリフルオロ−3−ヒドロキシ−1−アリール−1−ブタノン誘導体の精製法。
General formula [1]
Figure 0003830711
Wherein X represents hydrogen, C 1-6 alkyl, C 1-6 alkoxy, or a halogen atom (F, Cl, Br or I), and * represents an asymmetric carbon. A general formula having a high optical purity, characterized in that a racemic crystal is preferentially precipitated from a 4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative to improve the optical purity of the residue. A method for purifying the optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative represented by [1].
再結晶溶媒を使用または使用しないで行う請求項1に記載した精製法。The purification method according to claim 1, which is carried out with or without a recrystallization solvent. ラセミ種結晶を添加または添加しないで行う請求項1または2の何れかに記載した精製法The purification method according to claim 1, wherein the purification is performed with or without the addition of racemic seed crystals. 請求項1乃至請求項3の何れかに記載した方法を繰り返し行う精製法。A purification method in which the method according to any one of claims 1 to 3 is repeated.
JP2000019165A 2000-01-27 2000-01-27 Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative Expired - Fee Related JP3830711B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000019165A JP3830711B2 (en) 2000-01-27 2000-01-27 Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative
US09/770,671 US6642409B2 (en) 2000-01-27 2001-01-29 Process for producing 4,4,4-trifluoro-3-hydroxybutyric acid derivatives
US10/202,833 US6833468B2 (en) 2000-01-27 2002-07-26 Process for producing 4,4,4-trifluoro-3-hydroxybutyric acid derivatives
US10/212,840 US6639100B2 (en) 2000-01-27 2002-08-07 Process for producing 4,4,4,-trifluoro-3-hydroxybutyric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000019165A JP3830711B2 (en) 2000-01-27 2000-01-27 Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative

Publications (2)

Publication Number Publication Date
JP2001213838A JP2001213838A (en) 2001-08-07
JP3830711B2 true JP3830711B2 (en) 2006-10-11

Family

ID=18545914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000019165A Expired - Fee Related JP3830711B2 (en) 2000-01-27 2000-01-27 Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative

Country Status (1)

Country Link
JP (1) JP3830711B2 (en)

Also Published As

Publication number Publication date
JP2001213838A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
JPH11511742A (en) Chiral acid separation process with 1-aminoindan-2-ol
JPH01135747A (en) Optical active salt, its production and production of optically active 3-chloro-2-hydroxypropyltrimethyl ammonium chloride
JP3830711B2 (en) Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanone derivative
JP4138928B2 (en) Method for producing D-alloisoleucine and intermediate for production
JPH01216983A (en) Method for optical resolution of (+-)-tetrahydrofuran-2-carboxylic acid
JP4105797B2 (en) Method for purifying optically active α-trifluoromethyl lactic acid
EP0915080B1 (en) Process for preparing optically active amines and optically active carboxylic acids, and intermediates for preparation
JP3865572B2 (en) Method for purifying optically active 4,4,4-trifluoro-3-hydroxy-1-aryl-1-butanones
JPH04300877A (en) New optically resolving agent and production of optically active amine
BG64772B1 (en) Method for heavy metals elimination
JP3883525B2 (en) Method for purifying pravastatin sodium
JPH07330732A (en) Optically active 3-amino-1-benzylpiperidine derivative
JP3888402B2 (en) Process for producing optically active N-carbobenzoxy-tert-leucine
JP4752285B2 (en) Efficient optical resolution of trifluorolactic acid
JP2007217440A (en) Purification method for optically active alpha-trifluoromethyl lactate
JP4104319B2 (en) Process for producing optically active 2-hydroxy-3-nitropropionic acid
JP2007510715A (en) A new polymorph of atobacon and its preparation process
US20070238894A1 (en) Method for preparing pure fenofibrate
JP4768145B2 (en) Optical purification method of optically active 2-phenoxypropionic acid
JP2002293791A (en) Method for protected 2'-deoxycytidine derivative purification
JPS5980627A (en) Optical resolution of alpha-isopropyl-p-chlorophenylacetic acid
JPH024581B2 (en)
JP2000309557A (en) Production of optically active propionic acid derivative
JP2000198779A (en) Purification of 3-alkylflavanol derivative
JPS6143177A (en) Resolution of (+-)2-(2'-(p-fluorophenyl)-5'- benzoxazolyl)-propionic acid

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20060421

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060620

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060711

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060712

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 3

Free format text: PAYMENT UNTIL: 20090721

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090721

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100721

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 4

Free format text: PAYMENT UNTIL: 20100721

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 5

Free format text: PAYMENT UNTIL: 20110721

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 5

Free format text: PAYMENT UNTIL: 20110721

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120721

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120721

Year of fee payment: 6

LAPS Cancellation because of no payment of annual fees